Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis

ClinicalTrials.gov ID: NCT01328379

Public ClinicalTrials.gov record NCT01328379. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 1:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Two Doses of Oral Dalfampridine Extended Release Tablets (5 mg and 10 mg Twice Daily) in Patients With Multiple Sclerosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to investigate the safety and efficacy of a lower dose of dalfampridine extended release tablets compared to the currently approved dose in improving walking in Multiple Sclerosis (MS) patients.

Study identification

NCT ID
NCT01328379
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Acorda Therapeutics
Industry
Enrollment
430 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2011 (Type not available)
Primary completion
Apr 2012 (Actual)
Completion
Jul 2012 (Actual)
Last update posted
Sep 5, 2013

2011 – 2012

United States locations

U.S. sites
70
U.S. states
31
U.S. cities
62
Facility City State ZIP Site status
North Central Neurology Associates, PC Cullman Alabama — —
Phoenix Neurological Associates, Ltd Phoenix Arizona — —
Arizona Neurological Institute Sun City Arizona — —
Clinical Research Advantage Inc. Tempe Arizona — —
Sutter East Bay Physicians Medical Foundation Berkeley California — —
Neuro-Pain Medical Center, Inc. Fresno California — —
Loma Linda University Medical Center Loma Linda California — —
Collaborative NeuroScience Network, Inc. Long Beach California — —
University of California Davis Medical Center Sacramento California — —
Mount Sinai Rehabilitation Hospital Hartford Connecticut — —
Georgetown University Hospital Washington D.C. District of Columbia — —
Neurology Associates, PA Maitland Florida — —
University of Miami School of Medicine, Dept. of Neurology Miami Florida — —
Neurological Associates Pompano Beach Florida — —
Neurologique Foundation, Inc. Ponte Vedra Florida — —
Negroski, Sutherland and Hanes Neurology Sarasota Florida — —
Suncoast Neuroscience Associates, Inc. St. Petersburg Florida — —
Tallahassee Neurological Clinic, PA Tallahassee Florida — —
Axiom Clinical Research of Florida Tampa Florida — —
The Multiple Sclerosis Center of Vero Beach Vero Beach Florida — —
Sheperd Center, Inc. Atlanta Georgia — —
Northwestern University Chicago Illinois — —
Consultants in Neurology Ltd. Northbrook Illinois — —
Indiana University School of Medicine Indianapolis Indiana — —
Josephson Wallack Munshower Neurology, PC Indianapolis Indiana — —
Methodist Plaza Specialty Des Moines Iowa — —
Ruan Neurology Clinic and Research Center Des Moines Iowa — —
The University of Kansas Medical Center Kansas City Kansas — —
Associates in Neurology, PSC Lexington Kentucky — —
University of Maryland, Maryland Center for Multiple Sclerosis Baltimore Maryland — —
Lahey Clinic Lexington Massachusetts — —
Springfield Neurology Associates, LLC Springfield Massachusetts — —
Wayne State University Detroit Michigan — —
Advanced Neurology Specialists Great Falls Montana — —
Veterans Administration Sierra Neveda Health Care System Reno Nevada — —
Upstate Clinical Research, LLC Albany New York — —
NYU Langone Medical Center MS Comprehensive Care Center New York New York — —
Comprehensive Multiple Sclerosis Care Center at South Shore Neurologic Associates Patchogue New York — —
Island Neurological Associates, PC Plainview New York — —
University of Rochester Medical Center Rochester New York — —
PMG Research of Charlotte Charlotte North Carolina — —
The Neurological Institute, PA Charlotte North Carolina — —
PMG Research of Hickory, LLC Hickory North Carolina — —
Raleigh Neurology Associates Raleigh North Carolina — —
PMG Research of Winston-Salem Winston-Salem North Carolina — —
Altru Health System Clinic Grand Forks North Dakota — —
Northern Ohio Neuroscience, LLC Bellevue Ohio — —
Cleveland Clinic Foundation Cleveland Ohio — —
Neurological Research Institute Columbus Ohio — —
Ohio State University, Columbus Columbus Ohio — —
Neurology Specialists, Inc. Dayton Ohio — —
OMRF Multiple Sclerosis Center of Excellence Oklahoma City Oklahoma — —
Oregon Health and Science University Portland Oregon — —
Providence Multiple Sclerosis Center Portland Oregon — —
The Pennsylvania State University, Milton S. Hershey Medical Center Hershey Pennsylvania — —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania — —
Temple University School of Medicine Philadelphia Pennsylvania — —
The Neurology Foundation, Inc. Providence Rhode Island — —
Wesley Neurology Clinic, PC Cordova Tennessee — —
Advanced Neurosciences Institute Franklin Tennessee — —
Sibyl E. Wray, MD, Neurology, PC Knoxville Tennessee — —
Texas Neurology, PA Dallas Texas — —
Kelsey-Seybold Clinic Houston Texas — —
Maxine Mesinger Multiple Sclerosis Clinic; Baylor College of Medicine Houston Texas — —
Fletcher Allen Health Care Burlington Vermont — —
Hampton Roads Neurology Newport News Virginia — —
Neurological Associates Richmond Virginia — —
Virginia Commonwealth University Richmond Virginia — —
Swedish Neuroscience Institute Seattle Washington — —
Aurora Saint Luke's Medical Center Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01328379, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 5, 2013 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01328379 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →